| CCP-SLP | Certificate of Clinical Competence in Speech Language Pathology |
|---|---|
| ClP | clinical pathology |
| CP | candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta... |
| DipClinPath | Diploma in Clinical Pathology |
| FEDRIP | Federal Research in Progress [database] |
| humoral pathology | The thesis that disorders in the fluids of the body, especially the blood, are the basic factors in disease. (05 Mar 2000) |
|---|---|
| speech-language pathology | The study of speech or language disorders and their diagnosis and correction. (12 Dec 1998) |
| speech pathology | The science concerned with functional and organic speech defects and disorders. (05 Mar 2000) |
| surgical pathology | A field in anatomical pathology concerned with examination of tissues removed from living patients for the purpose of diagnosis of disease and guidance in the care of patients. (05 Mar 2000) |
| dental pathology | The branch of dentistry concerned with the aetiology, pathogenesis, and clinical, gross, and microscopic aspects of oral and paraoral disease, including oral soft tissues, the teeth, jaws, and salivary glands. Synonym: dental pathology. (05 Mar 2000) |
| symptoms and general pathology | manifestations of disease and pathological conditions which may occur in various diseases and different organs (12 Dec 1998) |
| oral pathology | The branch of dentistry concerned with the aetiology, pathogenesis, and clinical, gross, and microscopic aspects of oral and paraoral disease, including oral soft tissues, the teeth, jaws, and salivary glands. Synonym: dental pathology. (05 Mar 2000) |
| functional pathology | Pathology pertaining to abnormalities in function of a tissue, organ, or part, with or without associated changes in structure. (05 Mar 2000) |
| lupus glomerulonephritis-pathology | Patient survival and preservation of renal function are predictable from renal pathology as demonstrated by biopsy and defined by the histological classification of the International Study of Kidney Disease in Children/World Health Organization (ISKDC/WHO). Semi-quantitative indices of nephron loss (chronicity index) and activity of acute potentially reversible inflammation (activity index) are not predictive of individual outcome, renal failure or death in patients with aggressively treated SLE GN. (05 Mar 2000) |
| Addison's clinical planes | A series of plane's used as landmarks in thoracoabdominal topography; the trunk is divided vertically by a median plane from the upper border of the manubrium of the sternum to the pubic symphysis, by a lateral plane drawn vertically on either side through a point half way between the anterior superior iliac spine and the median plane at the interspinal plane, and by an interspinal plane passing vertically through the anterior superior iliac spine on either side; transversely the trunk is divided by a transthoracic plane passing across the thorax 3.2 cm above the lower border of the body of the sternum, by a transpyloric plane midway between the jugular notch of the sternum and the pubic symphysis, corresponding to the disc between the first and second lumbar vertebrae, and by an intertubercular plane passing through the iliac tubercles and cutting usually the fifth lumbar vertebra; the plane's formed on these lines, and also on transverse plane's cutting the upper edge of the manubrium and the upper edge of the pubic symphysis, constitute the clinical plane's of Addison. (05 Mar 2000) |
| chemistry, clinical | The specialty of analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy. (12 Dec 1998) |
| pharmacology, clinical | The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans. (12 Dec 1998) |
| phase I clinical trial | <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose. They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies. The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs. (31 Dec 1997) |
| phase II clinical trial | <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study. (31 Dec 1997) |
| phase III clinical trial | <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments. Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials. (31 Dec 1997) |